Climb Bio Correlations

CLYM Stock   1.48  0.07  4.96%   
The current 90-days correlation between Climb Bio and MagnaChip Semiconductor is 0.09 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Climb Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Climb Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Climb Bio Correlation With Market

Weak diversification

The correlation between Climb Bio and DJI is 0.36 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Climb Bio and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.

Moving together with Climb Stock

  0.68JNJ Johnson JohnsonPairCorr

Moving against Climb Stock

  0.5TRV The Travelers CompaniesPairCorr
  0.45WMT WalmartPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
MXADI
LADI
MXTSEM
TSEML
TSEMADI
MXL
  
High negative correlations   
MTGPFH

Risk-Adjusted Indicators

There is a big difference between Climb Stock performing well and Climb Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Climb Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Climb Bio Corporate Management

Chandra JDVP CounselProfile
Jo PalmerPhillipsChief OfficerProfile
Emily CPASenior OfficerProfile
Cindy MBASenior FinanceProfile
Emily PimblettChief OfficerProfile
Nishi MDSenior DevelopmentProfile